SCHEMBL734284

SCHEMBL734284

O=S(=O)(c1ccccc1)n1c(CCO)cc2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.56
PPARA Q07869 6/20 0.56
PPARD Q03181 4/20 0.56
IDE P14735 1/20 0.50
CA12 O43570 2/20 0.49
CA9 Q16790 2/20 0.49
CA2 P00918 1/20 0.49
ALDH1A1 P00352 2/20 0.48
LMNA P02545 2/20 0.48
RECQL P46063 1/20 0.48
MAPT P10636 1/20 0.48
NOD1 Q9Y239 4/20 0.44
NOD2 Q9HC29 3/20 0.44
SRC P12931 1/20 0.44
CCR2 P41597 1/20 0.44
MEN1 O00255 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
HTR6 P50406 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8829929 0.89 NOD1 (0.58) PPARGPPARAPPARDALDH1A1NOD1
SCHEMBL27247090 0.88 PPARG (0.52) PPARGPPARAPPARDIDECA12
SCHEMBL1466410 0.86 PPARG (0.75) PPARGPPARAPPARDIDECA12
SCHEMBL6867245 0.84 CA12 (0.54) PPARGPPARAPPARDIDECA12
SCHEMBL8691689 0.82 PPARG (0.52) PPARGPPARAPPARDIDECA12
SCHEMBL378955 0.82 CA12 (0.51) PPARGPPARAPPARDIDECA12
SCHEMBL14376541 0.82 PDE4B (0.45) PPARGPPARAPPARDNOD1NOD2
SCHEMBL549089 0.82 CA12 (0.51) PPARGPPARAPPARDIDECA12
SCHEMBL3523098 0.80 PPARG (0.58) PPARGPPARAPPARDIDEALDH1A1
SCHEMBL8687469 0.80 PPARG (0.48) PPARGPPARAPPARDIDECA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101516844-B 4-heteroaryl substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having activity on opioid receptor systems GRUENENTHAL GMBH 2013-12-11 CN disclosed
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
CN-101516844-A 4-heteroaryl substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having activity on opioid receptor systems GRUENENTHAL GMBH (DE) 2009-08-26 CN disclosed
EP-2044016-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2009-04-08 EP disclosed
WO-2008009415-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1- AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 PPARG 324/4885PPARA 212/4885PPARD 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.